Global and United States OTC Veterinary Drug Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and United States OTC Veterinary Drug Market Report & Forecast 2024-2034
Over-the-counter (OTC) veterinary drugs are medications that can be purchased directly by pet owners without a prescription from a veterinarian. These medications are typically used for the treatment and management of minor health conditions in animals.
Market Analysis and InsightsGlobal and United States OTC Veterinary Drug Market
This report focuses on global and United States OTC Veterinary Drug market, also covers the segmentation data of other regions in regional level and county level.
The global OTC Veterinary Drug revenue was US$ 8421 million in 2022 and is forecast to a readjusted size of US$ 13890 million by 2034 with a CAGR of 7.9% during the review period (2024-2034).
The increased demand for un-prescribed veterinary drugs, higher pet adoption, and humanization, expanding pet accessories, and vet medical stores are flourishing the demand for over-the-cover veterinary drugs.
Global OTC Veterinary Drug Scope and Market Size
OTC Veterinary Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global OTC Veterinary Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the OTC Veterinary Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.
Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC
Segment by Type
Oral
Injectable
Topical
Others
Veterinary Hospitals
Veterinary Clinics
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces OTC Veterinary Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of OTC Veterinary Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of OTC Veterinary Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Veterinary Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States OTC Veterinary Drug Market
This report focuses on global and United States OTC Veterinary Drug market, also covers the segmentation data of other regions in regional level and county level.
The global OTC Veterinary Drug revenue was US$ 8421 million in 2022 and is forecast to a readjusted size of US$ 13890 million by 2034 with a CAGR of 7.9% during the review period (2024-2034).
The increased demand for un-prescribed veterinary drugs, higher pet adoption, and humanization, expanding pet accessories, and vet medical stores are flourishing the demand for over-the-cover veterinary drugs.
Global OTC Veterinary Drug Scope and Market Size
OTC Veterinary Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global OTC Veterinary Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the OTC Veterinary Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.
By Company
Zoetis
Boehringer Ingelheim
Virbac S.A.
Hester Biosciences Ltd.
Merck Animal Health
Elanco Animal Health
Ceva Santé Animale
Vetoquinol S.A.
Phibro Animal Health Corporation
Dechra Pharmaceuticals PLC
Segment by Type
Oral
Injectable
Topical
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces OTC Veterinary Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of OTC Veterinary Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of OTC Veterinary Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Veterinary Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices